Tag
2 articles
This article explains how artificial intelligence is revolutionizing biotechnology through machine learning applications in drug discovery and protein engineering, using the recent Anthropic acquisition of Coefficient Bio as a case study.
Dutch biotech Laigo Bio has raised €17 million in seed funding to advance its innovative SureTACs platform, which targets previously 'undruggable' membrane proteins through protein degradation.
